News | April 29, 2025
Thermo Fisher Scientific to invest $2 billion to expand US operation
Investment demonstrates confidence in America’s commitment to science and innovation
Investment demonstrates confidence in America’s commitment to science and innovation
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform
Increased capability to produce medicines for challenging diseases including cancer
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Advances clinical research capabilities with leading regulatory grade registries platform
Testing supporting allergy diagnosis now accessible to more people in more communities
Bourgoin early development hub broadens offerings for oral solid dose formulations
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Subscribe To Our Newsletter & Stay Updated
